ImmunoTargets and Therapyhttps://www.dovepress.com/feed/journal/138New articles released by Dove Press for ImmunoTargets and Therapyen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press ImmunoTargets and TherapyImmunoTargets and Therapyhttps://www.dovepress.com/feed/journal/138https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140Irinotecan Modulates Immune Checkpoints in Neuroblastomahttps://www.dovepress.com/irinotecan-modulates-immune-checkpoints-in-neuroblastoma-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyFri, 12 Jun 2026 16:20:00 +1200https://doi.org/10.2147/ITT.S598469Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanomahttps://www.dovepress.com/myeloid-cell-derived-thrombospondin-1-mediates-anti-metastatic-effects-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapySat, 06 Jun 2026 01:15:00 +1200https://doi.org/10.2147/ITT.S596703Unveiling a ceRNA Network Involving IL-8 and TNF-α in Active Generalized Vitiligo by Multi-Omics Integrationhttps://www.dovepress.com/unveiling-a-cerna-network-involving-il-8-and-tnf--in-active-generalize-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyFri, 05 Jun 2026 03:15:00 +1200https://doi.org/10.2147/ITT.S595534Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myelomahttps://www.dovepress.com/integrin-alpha8beta1-is-identified-as-a-potential-car-t-target-for-bcm-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 28 May 2026 19:05:00 +1200https://doi.org/10.2147/ITT.S605729The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Managementhttps://www.dovepress.com/the-immune-architecture-of-eosinophilic-esophagitis-mechanisms-therape-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 27 May 2026 18:35:00 +1200https://doi.org/10.2147/ITT.S510865Comprehensive Review of Immunotherapy in Colorectal Cancer: From Mechanisms to Nursing Interventionshttps://www.dovepress.com/comprehensive-review-of-immunotherapy-in-colorectal-cancer-from-mechan-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 27 May 2026 03:05:00 +1200https://doi.org/10.2147/ITT.S603959Advances in the Management of Mediator-Related Symptoms in Non-Advanced Systemic Mastocytosishttps://www.dovepress.com/advances-in-the-management-of-mediator-related-symptoms-in-non-advance-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 25 May 2026 19:55:00 +1200https://doi.org/10.2147/ITT.S609692Identification of Prognostic Clinical Features in Grade 4 Immune-Related Adverse Events: A Triangulation Studyhttps://www.dovepress.com/identification-of-prognostic-clinical-features-in-grade4-immune-relate-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 25 May 2026 18:15:00 +1200https://doi.org/10.2147/ITT.S609130An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cellshttps://www.dovepress.com/an-exploratory-in-vitro-study-of-cytotoxicity-and-cytokine-profiling-o-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyFri, 22 May 2026 01:50:00 +1200https://doi.org/10.2147/ITT.S594441Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine Gliomahttps://www.dovepress.com/development-of-an-active-chimeric-il13r2-adc-for-diffuse-intrinsic-pon-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 19 May 2026 23:35:00 +1200https://doi.org/10.2147/ITT.S575767A Review of Aryl Hydrocarbon Receptor–Mediated Immune Regulation in Cutaneous Squamous Cell Carcinoma Progressionhttps://www.dovepress.com/a-review-of-aryl-hydrocarbon-receptormediated-immune-regulation-in-cut-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapySat, 16 May 2026 17:30:00 +1200https://doi.org/10.2147/ITT.S601152Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Datahttps://www.dovepress.com/carcinoembryonic-antigen-flare-under-oxaliplatin-based-chemotherapy-pr-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 14 May 2026 03:35:00 +1200https://doi.org/10.2147/ITT.S594176Role of Cytokines in Bone Diseases and Their Therapeutic Applicationhttps://www.dovepress.com/role-of-cytokines-in-bone-diseases-and-their-therapeutic-application-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 07 May 2026 04:10:00 +1200https://doi.org/10.2147/ITT.S604392Context-Dependent Survival Associations Between Interleukin-13 Expression and Immunotherapy in Advanced Solid Tumorshttps://www.dovepress.com/context-dependent-survival-associations-between-interleukin-13-express-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 04 May 2026 14:40:00 +1200https://doi.org/10.2147/ITT.S578703B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancerhttps://www.dovepress.com/b7-h3-cd276-as-target-for-t-cell-based-bispecific-antibody-therapy-of--peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyFri, 01 May 2026 04:45:00 +1200https://doi.org/10.2147/ITT.S577364Tumor-Promoting Crosstalk of MMP11⁺ Fibroblasts and SPP1⁺ Macrophages Drive Poor Prognosis in Breast Cancer: Integrated Multi-Omics Analysishttps://www.dovepress.com/tumor-promoting-crosstalk-of-mmp11-fibroblasts-and-spp1-macrophages-dr-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 29 Apr 2026 16:50:00 +1200https://doi.org/10.2147/ITT.S564498RNA Sequencing Analyses and Validation of Immune-Related Genes in EBV-Specific Cytotoxic T Lymphocytes During Latent Infectionhttps://www.dovepress.com/rna-sequencing-analyses-and-validation-of-immune-related-genes-in-ebv--peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 27 Apr 2026 19:40:00 +1200https://doi.org/10.2147/ITT.S568661Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohorthttps://www.dovepress.com/blinatumomab-for-pediatric-high-risk-b-cell-precursor-acute-lymphoblas-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 23 Apr 2026 21:40:00 +1200https://doi.org/10.2147/ITT.S603087New Insights on IgA Nephropathy from the Perspective of Active Lesions and Systemic Inflammatory Responseshttps://www.dovepress.com/new-insights-on-iga-nephropathy-from-the-perspective-of-active-lesions-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 21 Apr 2026 02:30:00 +1200https://doi.org/10.2147/ITT.S585437Multi-Omics Analysis Reveals m7G Methylation-Related Genes May Be Involved in TGF-β Signaling-Mediated Anti-PD-L1 Response in Bladder Cancerhttps://www.dovepress.com/multi-omics-analysis-reveals-m7g-methylation-related-genes-may-be-invo-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 14 Apr 2026 17:45:00 +1200https://doi.org/10.2147/ITT.S583577Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Modelhttps://www.dovepress.com/cryoablation-plus-immune-checkpoint-inhibitors-enhanced-dendritic-cell-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 07 Apr 2026 18:20:00 +1200https://doi.org/10.2147/ITT.S581990Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Managementhttps://www.dovepress.com/guillain-barr-syndrome-progress-in-diagnosis-biomarkers-neuroimaging-a-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 02 Apr 2026 19:20:00 +1300https://doi.org/10.2147/ITT.S390161Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin Lymphomahttps://www.dovepress.com/circulating-mir-148a-3p-correlates-with-inadequate-induction-response--peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyWed, 01 Apr 2026 04:30:00 +1300https://doi.org/10.2147/ITT.S577426Comparative Clinical and Electrophysiological Profiles of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes Mellitus: An Observational Studyhttps://www.dovepress.com/comparative-clinical-and-electrophysiological-profiles-of-chronic-infl-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 26 Mar 2026 05:40:00 +1300https://doi.org/10.2147/ITT.S592658Progress on Potential Therapeutic Targets for Sepsis-Related Cardiac Dysfunction: From Basic Research to Clinical Translationhttps://www.dovepress.com/progress-on-potential-therapeutic-targets-for-sepsis-related-cardiac-d-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapySat, 21 Mar 2026 04:35:00 +1300https://doi.org/10.2147/ITT.S580700Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiationhttps://www.dovepress.com/kasugamycin-inhibits-melanoma-lung-metastasis-and-chi3l1-driven-m2-lik-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 19 Mar 2026 23:50:00 +1300https://doi.org/10.2147/ITT.S563951The Role of PD-L1 in Lung Cancer: From Biology to Clinical Applicationhttps://www.dovepress.com/the-role-of-pd-l1-in-lung-cancer-from-biology-to-clinical-application-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyThu, 19 Mar 2026 03:05:00 +1300https://doi.org/10.2147/ITT.S591588NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosishttps://www.dovepress.com/nup85-as-a-pan-cancer-immune-biomarker-integrated-multi-omics-and-func-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyTue, 17 Mar 2026 18:30:00 +1300https://doi.org/10.2147/ITT.S541852The Conjugation of Antibodies to Heat Shock Protein 70 Activates Immune Responses Against Tumor Cellshttps://www.dovepress.com/the-conjugation-of-antibodies-to-heat-shock-protein-70-activates-immun-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapyMon, 16 Mar 2026 17:55:00 +1300https://doi.org/10.2147/ITT.S565942Lymphoproliferation in Inborn Errors of Immunity: Mechanisms, Manifestations and Clinical Management, with a Focus on ALPIDhttps://www.dovepress.com/lymphoproliferation-in-inborn-errors-of-immunity-mechanisms-manifestat-peer-reviewed-fulltext-article-ITTImmunoTargets and TherapySat, 07 Mar 2026 04:35:00 +1300https://doi.org/10.2147/ITT.S582718